Literature DB >> 26004846

Quantitative lipidomic analysis of plasma and plasma lipoproteins using MALDI-TOF mass spectrometry.

Jorge Serna1, David García-Seisdedos1, Alberto Alcázar2, Miguel Ángel Lasunción3, Rebeca Busto3, Óscar Pastor4.   

Abstract

Knowledge of the plasma lipid composition is essential to clarify the specific roles of different lipid species in various pathophysiological processes. In this study, we developed an analytical strategy combining high-performance liquid chromatography with evaporative light scattering detection (HPLC-ELSD) and off-line coupling with matrix-assisted laser desorption/ionization with time-of-flight mass spectrometry (MALDI-TOF/MS) to determine the composition of plasma and major lipoproteins at two levels, lipid classes and lipid species. We confirmed the suitability of MALDI-TOF/MS as a quantitative measurement tool studying the linearity and repeatability for triglycerides (TG), phosphatidylethanolamine (PE) and phosphatidylcholine (PC). Moreover, data obtained with this method were correlated with other lipid classes and species measurements using currently available technologies. To establish the potential utility of our approach, human plasma very low density- (VLDL), low density- (LDL) and high density- (HDL) lipoproteins from 10 healthy donors were separated using ultracentrifugation, and compositions of nine lipid classes, cholesteryl esters (CE), TG, free cholesterol (FC), PE, phosphatidylinositol (PI), sulfatides (S), PC, lysophosphatidylcholine (LPC) and sphingomyelin (SM), analyzed. In total, 157 lipid species in plasma, 182 in LDL, 171 in HDL, and 148 in VLDL were quantified. The lipidomic profile was consistent with known differences in lipid classes, but also revealed unexpected differences in lipid species distribution of lipoproteins, particularly for LPC and SM. In summary, the methodology developed in this study constitutes a valid approach to determine the lipidomic composition of plasma and lipoproteins.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Lipid classes; Lipid species; Lipidomics; Lipoproteins; MALDI; Mass spectrometry

Mesh:

Substances:

Year:  2015        PMID: 26004846     DOI: 10.1016/j.chemphyslip.2015.05.005

Source DB:  PubMed          Journal:  Chem Phys Lipids        ISSN: 0009-3084            Impact factor:   3.329


  18 in total

1.  Longitudinal association between phosphatidylcholines, neuroimaging measures of Alzheimer's disease pathophysiology, and cognition in the Mayo Clinic Study of Aging.

Authors:  Danni Li; Clinton Hagen; Ashely R Fett; Hai H Bui; David Knopman; Prashanthi Vemuri; Mary M Machulda; Clifford R Jack; Ronald C Petersen; Michelle M Mielke
Journal:  Neurobiol Aging       Date:  2019-03-18       Impact factor: 4.673

2.  Plasma Lipid Profiling Identifies Phosphatidylcholine 34:3 and Triglyceride 52:3 as Potential Markers Associated with Disease Severity and Oxidative Status in Chronic Obstructive Pulmonary Disease.

Authors:  Amel Ben Anes; Hela Ben Nasr; Zouhair Tabka; Oussama Tabka; Monia Zaouali; Karim Chahed
Journal:  Lung       Date:  2022-07-11       Impact factor: 3.777

3.  Targeted and global pharmacometabolomics in everolimus-based immunosuppression: association of co-medication and lysophosphatidylcholines with dose requirement.

Authors:  Dorothea Lesche; Vilborg Sigurdardottir; Alexander B Leichtle; Christos T Nakas; Uwe Christians; Lars Englberger; Martin Fiedler; Carlo R Largiadèr; Paul Mohacsi; Johanna Sistonen
Journal:  Metabolomics       Date:  2017-11-25       Impact factor: 4.290

4.  Characterization of brain-derived extracellular vesicle lipids in Alzheimer's disease.

Authors:  Huaqi Su; Yepy H Rustam; Colin L Masters; Enes Makalic; Catriona A McLean; Andrew F Hill; Kevin J Barnham; Gavin E Reid; Laura J Vella
Journal:  J Extracell Vesicles       Date:  2021-05-11

Review 5.  Are human iNKT cells keeping tabs on lipidome perturbations triggered by oxidative stress in the blood?

Authors:  Laura Felley; Jenny E Gumperz
Journal:  Immunogenetics       Date:  2016-07-08       Impact factor: 3.330

6.  A new peak detection algorithm for MALDI mass spectrometry data based on a modified Asymmetric Pseudo-Voigt model.

Authors:  Chalini D Wijetunge; Isaam Saeed; Berin A Boughton; Ute Roessner; Saman K Halgamuge
Journal:  BMC Genomics       Date:  2015-12-09       Impact factor: 3.969

Review 7.  Advances in Lipidomics for Cancer Biomarkers Discovery.

Authors:  Francesca Perrotti; Consuelo Rosa; Ilaria Cicalini; Paolo Sacchetta; Piero Del Boccio; Domenico Genovesi; Damiana Pieragostino
Journal:  Int J Mol Sci       Date:  2016-11-28       Impact factor: 5.923

Review 8.  Pharmacological Intervention to Modulate HDL: What Do We Target?

Authors:  Nicholas J Woudberg; Sarah Pedretti; Sandrine Lecour; Rainer Schulz; Nicolas Vuilleumier; Richard W James; Miguel A Frias
Journal:  Front Pharmacol       Date:  2018-01-22       Impact factor: 5.810

9.  Measurement of Ether Phospholipids in Human Plasma with HPLC-ELSD and LC/ESI-MS After Hydrolysis of Plasma with Phospholipase A1.

Authors:  Shiro Mawatari; Seira Hazeyama; Takehiko Fujino
Journal:  Lipids       Date:  2016-07-07       Impact factor: 1.880

10.  Plasma phospholipids and fatty acid composition differ between liver biopsy-proven nonalcoholic fatty liver disease and healthy subjects.

Authors:  D W L Ma; B M Arendt; L M Hillyer; S K Fung; I McGilvray; M Guindi; J P Allard
Journal:  Nutr Diabetes       Date:  2016-07-18       Impact factor: 5.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.